Healthcare and Pharmaceutical

These custom designs highlight deal toys within the healthcare space, but also include vial embedments for drug launches, and commemoratives for FDA approval milestones, therapeutic studies, in-human testing, and other industry landmarks.

FDA Approval Commemorative with Embedded Drug Vial

Custom Lucite, with an embedded drug vial, celebrating FDA approval of Cosela. (20ADH005)

1 Image

Syringe-Themed Deal Toy

Crystal deal toy, incorporating a 3D lasering etching of a syringe, commemorating the close of healthcare-focused LYFE Capital Fund III.

1 Image

Pharmaceutical Product Launch Commemorative

Lucite commemorative, incorporating a drug vial, celebrating the first product shipment by generic pharmaceutical company Civica.

1 Image

New Drug Application Custom Crystal

Custom crystal celebrating the submission of a New Drug Application (NDA) to the Food and Drug Administration (FDA). The application, related to Impel NeuroPharma’s migraine treatment INP104, was supported by a Phase 3, open-label STOP-301 Trial.

2 Images
Crystal commemorative marking the submission to the Food and Drug Administration (FDA) of a New Drug Application (NDA). INP104 was developed for the acute treatment of migraine headaches.

Pill-Themed Crystal Deal Toy

Pill-themed crystal deal toy commemorating a license agreement between Asahi Kasei Pharma Corporation, headquartered in Tokyo, and New York-based Woolsey Pharmaceuticals.

1 Image

Lung-Themed Crystal Deal Toy

Crystal deal toy, featuring a 3D laser-etch of lungs, commemorating a drug commercialization agreement in Japan. The collaboaration between biotherapeutics firm aTyr Pharma and Kyorin Pharmaceutical centers on a treatment for lung diseases.

1 Image

Medicinal Cannabis Deal Toy

Crystal deal toy celebrating the initial public offering by pharmaceutical firm Rua Bioscience. The New Zealand-based company is licensed to produce cannabis-derived medicines.

2 Images
Custom financial tombstone commemorating the ipo of New Zealand-based medicinal cannabis firm Rua Bioscience.